K041878

Substantially Equivalent

N LATEX CYSTATIN

Applicant: Dade Behring, Inc.
Product code: NDY
Advisory panel: Clinical Chemistry
Date received: 2004-07-12
Decision date: 2004-08-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Newark, DE, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.